Home > Clinical Trials

Saved trials

Recruiting
NCT05189015
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
80 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Angiotensin/Renin/Aldosterone Hypertension
Hypertension
Diabetes Mellitus, Type 2
Completed
NCT03524924
Edoxaban and Frailty in Senior Individuals
180 Enrollment(s)
1 Study location(s)
Observational
Atrial Fibrillation
Active, not recruiting
NCT05491460
Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects
24 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Anticoagulant Therapy
Recruiting
NCT03148457
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
2,000 Enrollment(s)
98 Study location(s)
Interventional (Not Applicable)
Ischaemic Stroke
Completed
NCT03723681
Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
7 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Acute Myeloid Leukemia (AML)
Recruiting
NCT04171726
Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation
100 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Aortic Valve Stenosis
Completed
NCT03395639
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
168 Enrollment(s)
48 Study location(s)
Interventional (Phase III)
Cardiac Disease
Completed
NCT05262322
Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation
234 Enrollment(s)
8 Study location(s)
Observational
Atrial Fibrillation